ASTROCYTOMA, IDH-MUTANT
Clinical trials for ASTROCYTOMA, IDH-MUTANT explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, IDH-MUTANT trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, IDH-MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Matched conditions: ASTROCYTOMA, IDH-MUTANT
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for brain cancer: experimental virus therapy targets aggressive tumors
Disease control Recruiting nowThis study tests whether adding two experimental drugs, DB107-RRV and DB107-FC, to standard treatment (radiation and chemotherapy) can help people with newly diagnosed high grade glioma, a fast-growing brain cancer. About 70 adults aged 18-75 will receive the drugs during and aft…
Matched conditions: ASTROCYTOMA, IDH-MUTANT
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC